CA2469523A1 - Dispositif de decompression des poumons - Google Patents

Info

Publication number

CA2469523A1

CA2469523A1 CA 2469523 CA2469523A CA2469523A1 CA 2469523 A1 CA2469523 A1 CA 2469523A1 CA 2469523 CA2469523 CA 2469523 CA 2469523 A CA2469523 A CA 2469523A CA 2469523 A1 CA2469523 A1 CA 2469523A1

Authority

CA

Canada

Prior art keywords

lung

lungs

air

oxygen

patient

Prior art date

2003-06-03

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 210000004072 lung Anatomy 0.000 title claims abstract description 378
• 230000009467 reduction Effects 0.000 title claims abstract description 28
• 239000012530 fluid Substances 0.000 claims abstract description 20
• 238000000034 method Methods 0.000 claims description 70
• 238000007789 sealing Methods 0.000 claims description 20
• 238000004891 communication Methods 0.000 claims description 10
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 90
• 239000001301 oxygen Substances 0.000 abstract description 90
• 229910052760 oxygen Inorganic materials 0.000 abstract description 90
• 238000009423 ventilation Methods 0.000 abstract description 57
• 239000000126 substance Substances 0.000 abstract description 41
• 238000002640 oxygen therapy Methods 0.000 abstract description 34
• 230000007774 longterm Effects 0.000 abstract description 24
• 230000006837 decompression Effects 0.000 abstract description 23
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract description 21
• 206010014561 Emphysema Diseases 0.000 abstract description 20
• 206010006451 bronchitis Diseases 0.000 abstract description 14
• 230000002685 pulmonary effect Effects 0.000 abstract description 13
• 206010006458 Bronchitis chronic Diseases 0.000 abstract description 10
• 208000007451 chronic bronchitis Diseases 0.000 abstract description 10
• 230000001936 parietal effect Effects 0.000 abstract description 8
• 230000009278 visceral effect Effects 0.000 abstract description 7
• 206010021143 Hypoxia Diseases 0.000 abstract description 5
• 230000007954 hypoxia Effects 0.000 abstract description 5
• 239000003570 air Substances 0.000 description 138
• 210000001519 tissue Anatomy 0.000 description 42
• 239000003795 chemical substances by application Substances 0.000 description 29
• 210000003437 trachea Anatomy 0.000 description 27
• 150000001875 compounds Chemical class 0.000 description 26
• 210000000115 thoracic cavity Anatomy 0.000 description 17
• 210000000779 thoracic wall Anatomy 0.000 description 16
• 210000000621 bronchi Anatomy 0.000 description 14
• 239000000463 material Substances 0.000 description 14
• 210000003491 skin Anatomy 0.000 description 14
• 210000003097 mucus Anatomy 0.000 description 13
• 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 12
• 230000029058 respiratory gaseous exchange Effects 0.000 description 12
• 210000004379 membrane Anatomy 0.000 description 11
• 239000012528 membrane Substances 0.000 description 11
• 210000003281 pleural cavity Anatomy 0.000 description 11
• 238000001356 surgical procedure Methods 0.000 description 11
• 230000006835 compression Effects 0.000 description 10
• 238000007906 compression Methods 0.000 description 10
• 230000006870 function Effects 0.000 description 10
• 210000004224 pleura Anatomy 0.000 description 10
• 238000012423 maintenance Methods 0.000 description 9
• 239000000853 adhesive Substances 0.000 description 8
• 230000001070 adhesive effect Effects 0.000 description 8
• 230000007423 decrease Effects 0.000 description 8
• 230000002829 reductive effect Effects 0.000 description 8
• 201000010099 disease Diseases 0.000 description 7
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
• 238000003780 insertion Methods 0.000 description 7
• 230000037431 insertion Effects 0.000 description 7
• 239000010410 layer Substances 0.000 description 7
• 210000003800 pharynx Anatomy 0.000 description 7
• 230000015556 catabolic process Effects 0.000 description 6
• 230000000241 respiratory effect Effects 0.000 description 6
• 230000008901 benefit Effects 0.000 description 5
• 210000003123 bronchiole Anatomy 0.000 description 5
• 210000004081 cilia Anatomy 0.000 description 5
• 238000004140 cleaning Methods 0.000 description 5
• 238000010276 construction Methods 0.000 description 5
• 230000006378 damage Effects 0.000 description 5
• 238000012377 drug delivery Methods 0.000 description 5
• 239000007789 gas Substances 0.000 description 5
• 210000000867 larynx Anatomy 0.000 description 5
• 230000007246 mechanism Effects 0.000 description 5
• 210000001331 nose Anatomy 0.000 description 5
• 201000003144 pneumothorax Diseases 0.000 description 5
• 230000000153 supplemental effect Effects 0.000 description 5
• 239000000454 talc Substances 0.000 description 5
• 229910052623 talc Inorganic materials 0.000 description 5
• SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 4
• 108010006654 Bleomycin Proteins 0.000 description 4
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
• 241000124008 Mammalia Species 0.000 description 4
• 229960001561 bleomycin Drugs 0.000 description 4
• OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 4
• 210000000038 chest Anatomy 0.000 description 4
• 230000001684 chronic effect Effects 0.000 description 4
• 238000002591 computed tomography Methods 0.000 description 4
• 238000009792 diffusion process Methods 0.000 description 4
• 229960003722 doxycycline Drugs 0.000 description 4
• 230000000694 effects Effects 0.000 description 4
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
• 239000010931 gold Substances 0.000 description 4
• 229910052737 gold Inorganic materials 0.000 description 4
• 239000002085 irritant Substances 0.000 description 4
• 231100000021 irritant Toxicity 0.000 description 4
• 238000002595 magnetic resonance imaging Methods 0.000 description 4
• 239000007769 metal material Substances 0.000 description 4
• 210000003928 nasal cavity Anatomy 0.000 description 4
• 230000008569 process Effects 0.000 description 4
• 230000005855 radiation Effects 0.000 description 4
• 230000002285 radioactive effect Effects 0.000 description 4
• 239000000565 sealant Substances 0.000 description 4
• 239000007787 solid Substances 0.000 description 4
• 238000011282 treatment Methods 0.000 description 4
• 210000004712 air sac Anatomy 0.000 description 3
• 239000000560 biocompatible material Substances 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 230000003182 bronchodilatating effect Effects 0.000 description 3
• 210000000254 ciliated cell Anatomy 0.000 description 3
• 230000008878 coupling Effects 0.000 description 3
• 238000010168 coupling process Methods 0.000 description 3
• 238000005859 coupling reaction Methods 0.000 description 3
• 238000013461 design Methods 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 239000003814 drug Substances 0.000 description 3
• 230000002427 irreversible effect Effects 0.000 description 3
• HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 3
• 229910001000 nickel titanium Inorganic materials 0.000 description 3
• 230000000737 periodic effect Effects 0.000 description 3
• 238000001959 radiotherapy Methods 0.000 description 3
• 230000001105 regulatory effect Effects 0.000 description 3
• 238000011272 standard treatment Methods 0.000 description 3
• 230000000472 traumatic effect Effects 0.000 description 3
• 206010011224 Cough Diseases 0.000 description 2
• 208000019693 Lung disease Diseases 0.000 description 2
• 239000004098 Tetracycline Substances 0.000 description 2
• 239000012080 ambient air Substances 0.000 description 2
• 230000004888 barrier function Effects 0.000 description 2
• 230000000740 bleeding effect Effects 0.000 description 2
• 229910002092 carbon dioxide Inorganic materials 0.000 description 2
• 239000001569 carbon dioxide Substances 0.000 description 2
• 230000003749 cleanliness Effects 0.000 description 2
• 239000011248 coating agent Substances 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 239000000470 constituent Substances 0.000 description 2
• 230000008602 contraction Effects 0.000 description 2
• 238000003745 diagnosis Methods 0.000 description 2
• 230000000916 dilatatory effect Effects 0.000 description 2
• 238000002224 dissection Methods 0.000 description 2
• 210000002919 epithelial cell Anatomy 0.000 description 2
• 238000002594 fluoroscopy Methods 0.000 description 2
• 238000003384 imaging method Methods 0.000 description 2
• 230000001771 impaired effect Effects 0.000 description 2
• 239000003550 marker Substances 0.000 description 2
• 239000013618 particulate matter Substances 0.000 description 2
• 210000003456 pulmonary alveoli Anatomy 0.000 description 2
• 238000002271 resection Methods 0.000 description 2
• 239000002356 single layer Substances 0.000 description 2
• 229960002180 tetracycline Drugs 0.000 description 2
• 229930101283 tetracycline Natural products 0.000 description 2
• 235000019364 tetracycline Nutrition 0.000 description 2
• 150000003522 tetracyclines Chemical class 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 238000002054 transplantation Methods 0.000 description 2
• FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
• 206010003598 Atelectasis Diseases 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 241001631457 Cannula Species 0.000 description 1
• MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
• 206010013975 Dyspnoeas Diseases 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 206010016717 Fistula Diseases 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 241000238413 Octopus Species 0.000 description 1
• 235000014676 Phragmites communis Nutrition 0.000 description 1
• 208000007123 Pulmonary Atelectasis Diseases 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 238000003915 air pollution Methods 0.000 description 1
• 230000003872 anastomosis Effects 0.000 description 1
• 210000003484 anatomy Anatomy 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 229920000249 biocompatible polymer Polymers 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 230000036760 body temperature Effects 0.000 description 1
• 210000004027 cell Anatomy 0.000 description 1
• 239000013043 chemical agent Substances 0.000 description 1
• 208000013116 chronic cough Diseases 0.000 description 1
• 230000001010 compromised effect Effects 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 238000012937 correction Methods 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000003292 diminished effect Effects 0.000 description 1
• 238000007598 dipping method Methods 0.000 description 1
• 230000009189 diving Effects 0.000 description 1
• 238000002651 drug therapy Methods 0.000 description 1
• 210000002615 epidermis Anatomy 0.000 description 1
• 210000002409 epiglottis Anatomy 0.000 description 1
• 230000003628 erosive effect Effects 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• 230000003890 fistula Effects 0.000 description 1
• 239000003292 glue Substances 0.000 description 1
• 230000035876 healing Effects 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 230000007794 irritation Effects 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 238000012153 long-term therapy Methods 0.000 description 1
• 238000011866 long-term treatment Methods 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 238000010297 mechanical methods and process Methods 0.000 description 1
• 230000005226 mechanical processes and functions Effects 0.000 description 1
• HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
• 229960004961 mechlorethamine Drugs 0.000 description 1
• 238000002324 minimally invasive surgery Methods 0.000 description 1
• 229960004023 minocycline Drugs 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 230000009972 noncorrosive effect Effects 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 230000010412 perfusion Effects 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 239000013047 polymeric layer Substances 0.000 description 1
• 230000009325 pulmonary function Effects 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 230000035807 sensation Effects 0.000 description 1
• 238000005549 size reduction Methods 0.000 description 1
• 238000004528 spin coating Methods 0.000 description 1
• 238000005507 spraying Methods 0.000 description 1
• 229910001220 stainless steel Inorganic materials 0.000 description 1
• 239000010935 stainless steel Substances 0.000 description 1
• 239000003894 surgical glue Substances 0.000 description 1
• 230000009747 swallowing Effects 0.000 description 1
• 238000010408 sweeping Methods 0.000 description 1
• 229940033134 talc Drugs 0.000 description 1
• 239000012780 transparent material Substances 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 238000013022 venting Methods 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1